Evidence map›Paper›PMID 29053861›Full record

Trial reportThe journals of gerontology. Series A, Biological sciences and medical sciences2018

Physical Function Following a Long-Term Lifestyle Intervention Among Middle Aged and Older Adults With Type 2 Diabetes: The Look AHEAD Study.

Denise K Houston, Rebecca H Neiberg, Michael E Miller, James O Hill, John M Jakicic, Karen C Johnson, Edward W Gregg, Van S Hubbard, Xavier Pi-Sunyer, W Jack Rejeski and 34 more

Registry-linked trialOpen access · bronzeAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in The journals of gerontology. Series A, Biological sciences and medical sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00017953 (Look AHEAD), which is not on this map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00017953 nacompletednot on this map

Look AHEAD: Action for Health in Diabetes

TypeinterventionalSponsorWake Forest University Health SciencesRan2001 to 2020Enrolled5,145ConditionsDiabetes, Myocardial Infarction, Stroke, Kidney DiseasesArmsLifestyle Intervention, Diabetes Support and Education
3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Trial
  4. Late-life disability following the action for health in diabetes (Look AHEAD) trial.The journals of gerontology. Series A, Biological sciences and medical sciences · 2026
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Article
  15. Review
  16. Observational
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

44 authors at 20 institutions in 1 country.

Denise K HoustonWake Forest School of Medicine, Winston-Salem, North Carolina.
Rebecca H NeibergWake Forest School of Medicine, Winston-Salem, North Carolina.
Michael E MillerWake Forest School of Medicine, Winston-Salem, North Carolina.
James O HillUniversity of Colorado Denver School of Medicine, Aurora.
John M JakicicUniversity of Pittsburgh, Pennsylvania.
Karen C JohnsonUniversity of Tennessee Health Science Center, Memphis.
Edward W GreggCenters for Disease Control, Atlanta, Georgia.
Van S HubbardNational Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland.
Xavier Pi-SunyerColumbia University Medical Center, New York, New York.
W Jack RejeskiWake Forest University, Winston-Salem, North Carolina.
Rena R WingBrown University and Miriam Hospital, Providence, Rhode Island.
John P BantleUniversity of Minnesota, Minneapolis.
Elizabeth BealeKeck School of Medicine of University of Southern California, Los Angeles.
Robert I BerkowitzPerelman School of Medicine, University of Pennsylvania, Philadelphia.
Maria Cassidy-BegaySouthwestern American Indian Center, Phoenix, Arizona.
Jeanne M ClarkJohns Hopkins School of Medicine, Baltimore, Maryland.
Mace CodayUniversity of Tennessee Health Science Center, Memphis.
Linda M DelahantyMassachusetts General Hospital, Boston.
Gareth DuttonUniversity of Alabama at Birmingham School of Medicine.
Caitlin EganWeight Control and Diabetes Research Center, Providence, Rhode Island.
John P ForeytBaylor College of Medicine, Houston, Texas.
Frank L GreenwayPennington Biomedical Research Center, Baton Rouge, Louisiana.
Helen P HazudaUniversity of Texas Health Science Center at San Antonio.
Andrea HergenroederUniversity of Pittsburgh, Pennsylvania.
Edward S HortonJoslin Diabetes Center, Harvard Medical School, Boston, Massachusetts.
Robert W JefferyUniversity of Minnesota, Minneapolis.
Steven E KahnUniversity of Washington, Seattle.
Anne KureUniversity of Washington, Seattle.
William C KnowlerNational Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, Arizona.
Cora E LewisUniversity of Alabama at Birmingham School of Medicine.
Corby K MartinPennington Biomedical Research Center, Baton Rouge, Louisiana.
Sara MichaelsIndian Health Service, Shiprock, New Mexico.
Maria G MontezUniversity of Texas Health Science Center at San Antonio.
David M NathanMassachusetts General Hospital, Boston.
Jennifer PatricioColumbia University Medical Center, New York, New York.
Anne PetersKeck School of Medicine of University of Southern California, Los Angeles.
Henry PownallBaylor College of Medicine, Houston, Texas.
Judith RegensteinerUniversity of Colorado Denver School of Medicine, Aurora.
Helmut SteinburgUniversity of Tennessee Health Science Center, Memphis.
Thomas A WaddenPerelman School of Medicine, University of Pennsylvania, Philadelphia.
Karen WhiteJohns Hopkins School of Medicine, Baltimore, Maryland.
Susan Z YanovskiNational Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland.
Ping ZhangCenters for Disease Control, Atlanta, Georgia.
Stephen B KritchevskyWake Forest School of Medicine, Winston-Salem, North Carolina.
Wake Forest University · USNational Institute of Diabetes and Digestive and Kidney Diseases · USUniversity of Tennessee Health Science Center · USBaylor College of Medicine · USCenters for Disease Control and Prevention · USColumbia University Irving Medical Center · USJohns Hopkins University · USMassachusetts General Hospital · USPennington Biomedical Research Center · USThe University of Texas Health Science Center at San Antonio · USUniversity of Alabama at Birmingham · USUniversity of Colorado Denver · USUniversity of Minnesota System · USUniversity of Pennsylvania · USUniversity of Pittsburgh · USUniversity of Southern California · USUniversity of Washington · USAmerican Indian Center · USBrown University · USIndian Health Service · US

Funding

UNIVERSITY OF PITTSBURGH CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE: BPCAUL1RR024153 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2006 to 2011
$73.9M
Look AHEAD: Action for Health in DiabetesU01DK057136 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ESPELAND, MARK ANDREW, WAGENKNECHT, LYNNE E · 1999 to 2020
$54.9M
ZOPOLRESTAT PHARMACOKINETICS IN DIABETICS WITH VARYING RENAL FUNCTIONM01RR000051 · NCRR · UNIVERSITY OF COLORADO DENVER · PI ALBERT, RICHARD K · 1985 to 2008
$52.6M
SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 1986 to 2026
$50.5M
Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Karin E Bornfeldt · 1986 to 2026
$41.4M
ZD6416 Analgesic--Painful Distal Symmetrical PolyneuropaM01RR001066 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI HALL, JANET E · 1985 to 2008
$37.4M
RESEARCH TRAININGP30DK026687 · NIDDK · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · PI Anthony W Ferrante, DYMPNA GALLAGHER · 1986 to 2026
$33.0M
PILOT STUDY--SUBSTRATE METABOLISM IN EXTREMELY LOW BIRTH WEIGHT INFANTSP30DK048520 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Edward L Melanson · 1995 to 2026
$32.6M
Why is the prevalence of obesity so high in U.S. Southern States? Regional predictors of BMI and obesity treatment response.P30DK056336 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BARBARA A GOWER · 2000 to 2026
$31.9M
WITHIN SUBJ VARIABILITY IN MEASUREMENTS DRUG METABOL ENZYMES IN HLTY SUBJM01RR000056 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEVINE, ARTHUR S · 1985 to 2006
$29.2M
VARIABILITY, STABILITY & SMOOTHNESS OF WALKINGP30AG024827 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Caterina Rosano · 2004 to 2026
$28.6M
Zevalin Radioimmunotherapy Using a Modified TreatmentM01RR000032 · NCRR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI RICH, ROBERT R. · 1985 to 2008
$23.6M
NCRR NIH HHS M01 RR000032NCRR NIH HHS M01 RR000051NCRR NIH HHS M01 RR000056NCRR NIH HHS M01 RR001066NCRR NIH HHS M01 RR001346NCRR NIH HHS M01 RR002719NCRR NIH HHS UL1 RR024153NIA NIH HHS P30 AG024827NIA NIH HHS P30 AG044271NIA NIH HHS P30 AG049638NIDDK NIH HHS P30 DK017047NIDDK NIH HHS P30 DK026687NIDDK NIH HHS P30 DK036836NIDDK NIH HHS P30 DK048520NIDDK NIH HHS P30 DK056336NIDDK NIH HHS P30 DK079626NIDDK NIH HHS P30 DK111022NIDDK NIH HHS U01 DK056990NIDDK NIH HHS U01 DK056992NIDDK NIH HHS U01 DK057002NIDDK NIH HHS U01 DK057008NIDDK NIH HHS U01 DK057078NIDDK NIH HHS U01 DK057131NIDDK NIH HHS U01 DK057135NIDDK NIH HHS U01 DK057136NIDDK NIH HHS U01 DK057151NIDDK NIH HHS U01 DK057154NIDDK NIH HHS U01 DK057171NIDDK NIH HHS U01 DK057177NIDDK NIH HHS U01 DK057178NIDDK NIH HHS U01 DK057182NIDDK NIH HHS U01 DK057219
6 · The paper itself

Abstract

Background: Lifestyle interventions have been shown to improve physical function over the short term; however, whether these benefits are sustainable is unknown. The long-term effects of an intensive lifestyle intervention (ILI) on physical function were assessed using a randomized post-test design in the Look AHEAD trial. Methods: Overweight and obese (body mass index ≥ 25 kg/m2) middle-aged and older adults (aged 45-76 years at enrollment) with type 2 diabetes enrolled in Look AHEAD, a trial evaluating an ILI designed to achieve weight loss through caloric restriction and increased physical activity compared to diabetes support and education (DSE), underwent standardized assessments of performance-based physical function including a 4- and 400-m walk, lower extremity physical performance (expanded Short Physical Performance Battery, SPPBexp), and grip strength approximately 11 years postrandomization and 1.5 years after the intervention was stopped (n = 3,783). Results: Individuals randomized to ILI had lower odds of slow gait speed (<0.8 m/s) compared to those randomized to DSE (adjusted OR [95% CI]: 0.84 [0.71 to 0.99]). Individuals randomized to ILI also had faster gait speed over 4- and 400-m (adjusted mean difference [95% CI]: 0.019 [0.007 to 0.031] m/s, p = .002, and 0.023 [0.012 to 0.034] m/sec, p < .0001, respectively) and higher SPPBexp scores (0.037 [0.011 to 0.063], p = .005) compared to those randomized to DSE. The intervention effect was slightly larger for SPPBexp scores among older versus younger participants (0.081 [0.038 to 0.124] vs 0.013 [-0.021 to 0.047], p = .01). Conclusions: An intensive lifestyle intervention has modest but significant long-term benefits on physical function in overweight and obese middle-aged and older adults with type 2 diabetes. ClinicalTrials.gov Identifier: NCT00017953.

Indexed as

Life StyleAgedCaloric RestrictionDiabetes Mellitus, Type 2ExerciseFemaleHand StrengthHumansMaleMiddle AgedObesityOverweightPhysical Functional PerformanceWalking SpeedWeight Reduction Programs

Identifiers

PMID29053861
PMCPMC6175031
OpenAlexW2766850217

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.